• 목록
• 답변
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during breastfeeding and pregnancy is a challenge for women suffering from the condition. Little data exists about how long-term exposure to these medications can affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological developmental conditions like hearing loss or impaired vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication should consider the benefits of taking it versus the dangers for the baby. Physicians don't have the data needed to provide clear recommendations, but they can provide information on the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy did not have a higher risk of fetal malformations, or structural birth defects. Researchers conducted a large population-based case-control study to determine the prevalence of major structural birth defects in babies born to mothers who had taken stimulants during early pregnancy and those who had not. Pediatric cardiologists and clinical geneticists examined the cases to ensure correct case classification and to limit the chance of bias.

However, the researchers' study had its limitations. The most important issue was that they were unable to distinguish the effects of the medication from those of the underlying disorder. That limitation makes it difficult to determine whether the small differences observed in the groups that were exposed result from medication use or confounding by comorbidities. The researchers did not examine the long-term effects for the offspring.

The study showed that babies whose mothers had taken ADHD medication during pregnancy had a higher risk of admission to the neonatal care unit (NICU) in comparison to mothers who did not take any medication during pregnancy or had discontinued taking their medication prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the higher risk of admission did not appear to be influenced by which stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having to have a caesarean section or one whose baby scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication taken during pregnancy.

The researchers suggest that the risk of a small amount with the use of managing adhd without medication adults medications during early pregnancy may be offset by the higher benefit for both mother and child of continued treatment for the woman's condition. Physicians should speak with their patients about this and try to help them develop coping skills that can lessen the effects of her disorder on her daily functioning and her relationships.

Interactions with Medication

More and more doctors are confronted with the dilemma of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are frequently made without clear and authoritative evidence. Instead, doctors have to weigh their own knowledge in conjunction with the experiences of other physicians and the research on the subject.

The issue of potential risks to the infant can be particularly tricky. The research that has been conducted on this topic is based on observations rather than controlled studies and the results are conflicting. Most studies restrict their analysis to live-births, which could underestimate the teratogenic impact which can cause abortions or terminations of pregnancy. The study that is discussed in the journal club addresses these limitations by analyzing information on deceased and live births.

The conclusion The conclusion: While certain studies have demonstrated that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have found no connection, and most studies have a neutral or slight negative effect. In all cases an in-depth study of the benefits and risks must be performed.

For many women with ADHD who suffer from ADHD, the decision to discontinue medication is difficult if not impossible. In fact, in a recent article in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of isolation and family conflict for these patients. A loss of medication may affect the ability to drive safely and perform work-related tasks, which are crucial aspects of daily life for people with ADHD.

She suggests that women who are unsure whether to take the medication or discontinue it due to pregnancy educate family members, coworkers and friends about the condition, its impact on daily functioning and the benefits of continuing the current treatment plan. In addition, educating them can help the woman feel supported in her struggle with her decision. Some medications can pass through the placenta. If the patient decides to stop taking her ADHD medication while pregnant and breastfeeding, it's important to be aware that the drug could be passed on to her baby.

Birth Defects and Risk of

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns over the impact that these medications could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Researchers used two massive datasets to analyze over the counter adhd medication 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. Researchers discovered that, while the overall risk is low, first-trimester ADHD exposure to medication was associated with slightly higher rates of certain heart defects, like ventriculoseptal defect.

The authors of the study did not discover any connection between early use of medication and congenital anomalies like facial deformities, or club feet. The results are in the same vein as previous studies which showed an insignificant, but small increase in cardiac malformations for women who started taking ADHD medication prior to pregnancy. The risk increased in the latter part of pregnancy, when a lot of women stopped taking their medication.

Women who used ADHD medications in the first trimester of their pregnancy were also more likely to undergo caesarean sections, a low Apgar score after delivery and a baby who required breathing assistance during birth. However the researchers of the study were not able to eliminate selection bias by limiting the study to women who didn't have any other medical conditions that could have contributed to these findings.

Researchers hope their research will help doctors when they see pregnant women. The researchers advise that while discussing the risks and benefits are important, the choice about whether to continue or stop medication should be according to the severity of each woman's ADHD symptoms and her requirements.

The authors warn that, although stopping the medication is a possibility to look into, it is not recommended because of the high incidence of depression and mental health issues in women who are expecting or have recently given birth. Additionally, the research suggests that women who decide to stop taking their medications are more likely to experience difficulties adjusting to life without them after the birth of their baby.

Nursing

The responsibilities of a new mother can i get adhd meds without a diagnosis be overwhelming. Women who suffer from adhd medication online who have to deal with their symptoms while attending doctor appointments and getting ready for the arrival of a baby and getting used to new routines at home are often faced with a number of difficulties. This is why many women choose to continue taking their ADHD medication throughout the pregnancy.

The risk for nursing infant is low because the majority of stimulant medications passes through breast milk at low levels. However, the amount of exposure to medication by the newborn may differ based on dosage, frequency it is administered and at what medication is prescribed for adhd time it is administered. Additionally, different medications enter the baby’s system through the gastrointestinal tract or through breast milk. The impact on the health of a newborn isn't completely known.

Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the absence of research. It is a difficult decision for the woman, who must weigh the benefits of her medication against the risk to the fetus. In the meantime, until more information is available, doctors should ask all pregnant patients about their history of ADHD and if they plan or are taking to take medication during the perinatal time.

Numerous studies have proven that women can continue to take their ADHD medication safely during pregnancy and breast-feeding. As a result, more and more patients are choosing to do so, and in consultation with their physician, they have found that the benefits of keeping their current medication far outweigh any potential risks.

Women who suffer from ADHD who are planning to breastfeed should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss the medication they are taking with their physician as well as the pros and cons for continuing treatment. This includes non medication Treatment for adhd adults-pharmacological methods. Psychoeducation should also be provided to help pregnant women suffering from ADHD understand their symptoms and the root cause, learn about available treatments and to reinforce existing coping strategies. This should involve a multidisciplinary approach, which includes the GP, obstetricians and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother as well as the child, monitoring of indicators of deterioration, and, if needed adjustments to the medication regimen.